<?xml version="1.0" encoding="UTF-8"?>
<p>According to the European and Portuguese guidelines for antiretroviral treatment [
 <xref rid="pone.0218226.ref008" ref-type="bibr">8</xref>,
 <xref rid="pone.0218226.ref009" ref-type="bibr">9</xref>], a baseline resistance test should be performed to determine transmitted drug resistance (TDR), which can impact the first-line antiretroviral response [
 <xref rid="pone.0218226.ref010" ref-type="bibr">10</xref>]. The last nationwide survey was carried out in 2003 and showed 7.8% of TDR [
 <xref rid="pone.0218226.ref011" ref-type="bibr">11</xref>]. Surveillance of TDR is important for the development of treatment guidelines, especially in Portugal where considerable migration from Portuguese speaking countries occurs, including some African countries where the levels of TDR are increasing along with the recent scaling-up of NRTI and NNRTI based treatments [
 <xref rid="pone.0218226.ref012" ref-type="bibr">12</xref>,
 <xref rid="pone.0218226.ref013" ref-type="bibr">13</xref>].
</p>
